National and Kapodistrian University of Athens
Η επίδραση της ροσουβαστατίνης στην αρτηριακή λειτουργία και στους δείκτες φλεγμονής και θρόμβωσης σε ασθενείς με οικογενή υπερχοληστερολαιμία ή οικογενή συνδυασμένη υπερλιπιδαιμία
Abstract
dc:descriptionIntroduction: Familial hypercholesterolemia (FH) and familial combined hyperlipidemia (FCH) are common hereditary dyslipidemias which are related to increased cardiovascular risk. Indexes of arterial function (arterial stiffness, reflected waves and endothelial function) and subclinical atherosclerosis (carotid wall thickness) are recognized predictors of cardiac outcomes. In this study, we evaluated the effect of the above dyslipidemias on arterial function and structure; we also investigated the efficacy of long-term treatment with rosuvastatin and the its effects on arterial properties.Methods: This study is comprised of 2 substudies. In the 1st case-control substudy, we enrolled 99 FH patients, 110 FCH patients and 61 normolipidemic controls and explored differences in arterial function (endothelium-dependent vasodilation of brachial artery –FMD-, carotid-femoral pulse wave velocity –PWV-, central augmentation index –AIx@75) and arterial structure (carotid intima-media thickness –ΙΜΤ) and correlations with lipid levels and inflammatory indexes. In the 2nd longitudinal substudy, we explored the changes of the above arterial parameters in 36 FH patients and 34 FCH patients at least 6 months and at least 1 year after starting treatment with rosuvastatin, and determinants of those changes were investigated. Importantly, none of the patients were taking statins or had other risk factors at enrollment.Results: Both FH and FCH patients had impaired arterial function (increased arterial stiffness and reflected waves, endothelial dysfunction) and subclinical carotid atherosclerosis compared with the normolipidemic subjects. FCH patients had also activation of subclinical inflammation. Rosuvastatin improved indexes of arterial function and structure in both FH and FCH patients. Arterial stiffness was decreased and endothelial dysfunction and carotid atherosclerosis improved with rosuvastatin. Rosuvastatin significantly also improved the levels of ‘classical’ lipids (total, LDL and HDL cholesterol and triglycerides), but those lipid changes had no correlation with arterial changes. In contrast, duration and intensity of treatment (dose x duration product) and biochemical variables such as CRP, apolipoproteins A1 and Β and lipoprotein A were determinants of the rosuvastatin induced improvement of arterial properties.Conclusions: The present study shows that FH and FCH patients have impaired arterial properties and subclinical atherosclerosis. Inflammatory activation plays a role in FCH patients. Rosuvastatin improves lipid levels and also improves arterial properties in both populations. The degree of arterial changes induced by rosuvastatin is not adequately determined by the changes of ‘classical’ lipids. On the other hand, the duration/intensity of treatment and also the change of inflammatory markers and ‘novel’ lipid variables seem to partly explain the observed arterial changes. These findings may have potential implications on the treatment of patients with hereditary dyslipidemias, given that arterial structure and function comprises a strong predictor of cardiovascular risk.
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2014
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Masoura, Konstantina
- Μασούρα, Κωνσταντίνα
Subjects
dc:subject × 16- Οικογενής υπερχοληστερολαιμία
- Οικογενής συνδυασμένη υπερλιπιδαιμία
- Ενδοθηλιακή λειτουργία
- Αρτηριακή σκληρία
- Αθηροσκλήρωση
- Familial hypercholesterolemia
- Familial combined hyperlipidemia
- Endothelial function
- Arterial stiffness
- Atherosclerosis
- Ιατρική και Επιστήμες Υγείας
- Κλινική Ιατρική
- Επιστήμες Υγείας
- Medical and Health Sciences
- Clinical Medicine
- Health Sciences
Rights
dc:rights- Statement dc:rights
-
- BY_NC_SA
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/41639